Review
Version 1
Preserved in Portico This version is not peer-reviewed
Probiotics in Cancer
Version 1
: Received: 4 August 2020 / Approved: 5 August 2020 / Online: 5 August 2020 (09:27:01 CEST)
How to cite: Lu, K.; Wu, X.; Jin, R.; Chen, H. Probiotics in Cancer. Preprints 2020, 2020080116. https://doi.org/10.20944/preprints202008.0116.v1 Lu, K.; Wu, X.; Jin, R.; Chen, H. Probiotics in Cancer. Preprints 2020, 2020080116. https://doi.org/10.20944/preprints202008.0116.v1
Abstract
In recent years, the consumption of over-the-counter probiotics used to promote health has grown rapidly worldwide and become an industry. In medicine, various studies have proven that probiotics can help improve the immune system and intestinal health. They are usually safe, but in some rare cases, they may cause concerning adverse reactions. Although the use of probiotics has been widely popularized in the public, the results of many probiotics clinical trials are contradictory. Especially for the cancer patients, the feasibility of probiotics management to provide benefits by targeting cancer and lessening anti-cancer side effects requires further investigations. And this review summarizes the interactions between probiotics and the host and current pros and cons of applying probiotics in the cancer patients.
Keywords
probiotics; cancer; safety; clinical trials
Subject
Medicine and Pharmacology, Gastroenterology and Hepatology
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment